Presidio Management Group X LLC - 15 Nov 2021 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role: 10%+ Owner
Signature: Dale Holladay, Attorney in Fact for each Reporting Person
Issuer symbol: EFTR on OTC
Transactions as of: 15 Nov 2021
Net transactions value: -$221,523
Form type: 4
Filing time: 17 Nov 2021, 18:55:42 UTC
Previous filing: 12 Nov 2021
Next filing: 22 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EFTR	Common Stock	Sale	$48,211	-4,914	-0.11%	$9.81^*	4,583,604	15 Nov 2021	Directly owned by USVP X	F1, F2
transaction	EFTR	Common Stock	Sale	$1,540	-157	-0.11%	$9.81^*	146,637	15 Nov 2021	Directly owned by AFF X	F1, F2
transaction	EFTR	Common Stock	Sale	$75,936	-8,062	-0.18%	$9.42^*	4,575,542	16 Nov 2021	Directly owned by USVP X	F1, F2
transaction	EFTR	Common Stock	Sale	$2,421	-257	-0.18%	$9.42^*	146,380	16 Nov 2021	Directly owned by AFF X	F1, F2
transaction	EFTR	Common Stock	Sale	$90,522	-9,918	-0.22%	$9.13^*	4,565,624	17 Nov 2021	Directly owned by USVP X	F1, F2
transaction	EFTR	Common Stock	Sale	$2,894	-317	-0.22%	$9.13^*	146,063	17 Nov 2021	Directly owned by AFF X	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $10.16, inclusive for sales on 11/15/21; prices ranging from $9.25 to $9.58, inclusive for sales on 11/16/21; prices ranging from $8.90 to $9.35, inclusive for sales on 11/17/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2	Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $10.16, inclusive for sales on 11/15/21; prices ranging from $9.25 to $9.58, inclusive for sales on 11/16/21; prices ranging from $8.90 to $9.35, inclusive for sales on 11/17/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.